|
AU2003245935A1
|
|
Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells
|
|
AU2003240613A1
|
|
Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
|
|
AU2002328863A1
|
|
Oncosuppressive gene
|
|
AU7753601A
|
|
2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity
|
|
HU0203524A2
|
|
2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity, their use and pharmaceutical compositions containing them
|
|
IL149212D0
|
|
Liposome formulation of 6,9-bis- (2-aminoethyl) amino] [g] isoquinoline-5,10-dione dimaleate
|
|
AU6278700A
|
|
1,2-dihydro-1-oxo-pyrazino[1,2-a]indole derivatives
|
|
AU6831500A
|
|
1h-pirido[3, 4-b]indol-1-one derivatives
|
|
WO0109149A1
|
|
Bisplatinum complexes active through the oral route
|
|
AU5825100A
|
|
Nitrates of bis-platinum complexes with polyamine ligands
|
|
AU4103300A
|
|
Heterocyclic compounds having antitumor activity
|
